Why is Sun Pharma betting $11.75B on a struggling US drugmaker?
In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash…
Input your search keywords and press Enter.